Increased plasma heparanase activity in COVID-19 patients https://t.co/FUobVuHJpk #medRxiv
Increased Plasma Heparanase Activity in COVID-19 Patients.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2020 – Aug 2024Where it's discussed
-
X / Twitter7 posts
-
News3 articles
-
YouTube2 videos
AI synopsis
What people are saying
The social discussions reflect a high level of interest and engagement, with comments exploring the mechanisms like blood vessel leakage and the therapeutic potential of HBPM, supported by references to related hypotheses. Words such as 'interesting' and 'plaisant' convey curiosity and tentative support, indicating that the research prompts thoughtful consideration of COVID-19's pathology and possible interventions.
Most discussions find the findings plausible and supportive of further research, especially with comments praising the hypothesis about heparanase's role in COVID-19 severity.
Participants show high curiosity, engaging with detailed mechanisms such as blood vessel leakage and the effects of heparanase, indicating a strong interest in the research.
Responses include referencing other studies, hypothesizing about treatments like HBPM, and debating the biological processes, demonstrating a thoughtful level of engagement.
While the discussions acknowledge the potential implications for understanding severe COVID-19 complications and treatment options, they remain somewhat speculative, so the perceived impact is moderate.
Abstract in brief
- The study suggests that COVID-19 patients have higher levels of heparanase activity and heparan sulfate in their blood, which are linked to worse disease severity and the need for intensive care.
- Heparanase is an enzyme that damages the endothelial glycocalyx, leading to blood vessel leakage and inflammation, which are common issues in severe COVID-19 cases.
- Since low molecular weight heparins (LMWH) can inhibit heparanase activity, using LMWH as a treatment for COVID-19 patients might help reduce vascular damage and improve outcomes, making it a potential therapeutic option to explore.]
Top posts
Most liked on X and Bluesky@BouBouCharlie @MarcGozlan @DrGomi @APHP Bsr https://t.co/ubl0oWdQti Comment dire ? et ça tient la route … fuite capillaire pulmonaire et autres organes, hypoalbuminemie, proteinurie, destruction glycocalyx, activation plaquettes et mastocytes, effet bénéfique des HBPM, etc. Son hypothèse me plait bien …
MMPは心筋炎~拡張型心筋症へ進行:ECM remodelling,抗
ref https://t.co/ubl0oWdQti Un taux élevé d'heparanase a un intérêt dans la détermination de la sévérité des complications pulmonaires (fuite capillaire et thrombose) ou autres organes (rein), l'action de HBPM est soulignée HCQ semble également agir sur heparanase (cf thèse
RT @medrxivpreprint: Increased plasma heparanase activity in COVID-19 patients https://t.co/FUobVuHJpk #medRxiv
All mentions
Understanding SARS-CoV-2: Insights on Virus Entry Mechanisms
This video discusses how we learn about SARS-CoV-2 entry into human cells through its spike protein binding to the ACE2 receptor. It highlights the unique attributes of the virus and its implications for understanding…
Understanding SARS-CoV-2 Spike Protein and Virus Entry Mechanism
This video explains the mechanisms of viral attachment and entry, particularly focusing on how SARS-CoV-2 enters human cells by binding to the ACE2 receptor. We explore the significance of the spike protein and its…
MMPは心筋炎~拡張型心筋症へ進行:ECM remodelling,抗
@BouBouCharlie @MarcGozlan @DrGomi @APHP Bsr https://t.co/ubl0oWdQti Comment dire ? et ça tient la route … fuite capillaire pulmonaire et autres organes, hypoalbuminemie, proteinurie, destruction glycocalyx, activation plaquettes et mastocytes, effet bénéfique des HBPM, etc. Son hypothèse me plait bien …
ref https://t.co/ubl0oWdQti Un taux élevé d'heparanase a un intérêt dans la détermination de la sévérité des complications pulmonaires (fuite capillaire et thrombose) ou autres organes (rein), l'action de HBPM est soulignée HCQ semble également agir sur heparanase (cf thèse
RT @medrxivpreprint: Increased plasma heparanase activity in COVID-19 patients https://t.co/FUobVuHJpk #medRxiv
RT @COVID19arXiv:
Increased plasma heparanase activity in COVID-19 patients https://t.co/FUobVuHJpk #medRxiv